KBC Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
KBC Group's ABMD Position: Q4 2022 in Review
KBC Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,726 shares — an estimated $915K sold.
KBC Group first reported a position in ABMD in Q1 2015 and held it in 22 quarters. The position peaked at $10.1M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- KBC Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- KBC Group sold 3,726 Abiomed Inc shares in Q4 2022, an estimated $915K.
- KBC Group first reported a position in Abiomed Inc in Q1 2015 and held it in 22 quarters.
- KBC Group's Abiomed Inc position peaked at $10.1M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on KBC Group's 13F filing for Q4 2022, filed 13 Feb 2023.